T. Rowe Price Associates »

Bioage Labs shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Bioage Labs shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Bioage Labs

Tip: Access up to 7 years of quarterly data

All positions including Bioage Labs held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioage Labs by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.4M 450k 20.80

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Nvidia Corporation Comm Stk (NVDA)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Tesla Comm Stk (TSLA)
Intuitive Surgical Comm Stk (ISRG)
Thermo Fisher Scientific Comm Stk (TMO)

View all positions for T. Rowe Price Associates

Top funds holding Bioage Labs

AH Capital Management
Sofinnova Ventures
RA Capital Management
OrbiMed Advisors
Sands Capital Ventures
Pivotal bioVenture Partners Investment Advisor
T. Rowe Price Associates
Redpoint Management
Siren
Emerald Advisers
Daniel D. Thurber
Emerald Mutual Fund Advisers, Trust
Citadel Advisors
Jpmorgan Chase & Co
Marshall Wace

View all funds holding Bioage Labs